Bio-Rad Laboratories
Rethink PCR
Our top 5 favorite slogans

A big thank you to everyone who participated in the rethink PCR competition! We had a great time looking through the thousands of excellent rethink PCR slogans. To the left are our top five favorite slogans. Public voting for your favorite slogan has closed and we are excited to announce the winner — Barbara Gandolfi of the Center for Companion Animal Health (CCAH) at University of California, Davis.

Click here to learn more about Barbara and her lab's work and to see pictures of her receiving her first prize of an iPhone and modeling the winning slogan T-shirt.

Bio-Rad continues to rethink PCR — keep watching this space. To let us know more about what you think about PCR, click here.

Bio-Rad 1000-Series Thermal Cyclers Play Some Games


Privacy Statement | Terms of Use

Purchase of this instrument conveys a limited non-transferable immunity from suit for the purchaser's own internal research and development and for use in applied fields other than Human In Vitro Diagnostics under one or more of U.S. Patents Nos. 5,656,493, 5,333,675, 5,475,610 (claims 1, 44, 158, 160-163 and 167 only), and 6,703,236 (claims 1-7 only), or corresponding claims in their non-U.S. counterparts, owned by Applera Corporation. No right is conveyed expressly, by implication or by estoppel under any other patent claim, such as claims to apparatus, reagents, kits, or methods such as 5' nuclease methods. Further information on purchasing licenses may be obtained by contacting the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA.

Bio-Rad's real-time thermal cyclers are licensed real-time thermal cyclers under Applera's United States Patent No. 6,814,934 B1 for use in research and for all other fields except the fields of human diagnostics and veterinary diagnostics.

These products are covered by one or more of the following U.S. patents or their foreign counterparts owned by Eppendorf AG: U.S. Patent Nos. 6,767,512 and 7,074,367.